The difference in clinical presentations between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea

Yonsei Medical Journal

Volumn 52, Issue 2, 2011, Pages 282-287

  Jeon, Eun Ju ^a   Cho, Sung Gun ^a   Shin, Jong Wook ^a   Kim, Jae Yeol ^a   Park, In Won ^a   Choi, Byoung Whui ^a   Choi, Jae Chol ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

Epidemiology; Health care; Pneumonia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH CARE; HEALTHCARE ASSOCIATED PNEUMONIA; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PNEUMONIA; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; PNEUMONIA, STAPHYLOCOCCAL; REPUBLIC OF KOREA; TREATMENT OUTCOME;

EID: 79952787752     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2011.52.2.282     Document Type: Article

References (24)

1. Slaven EM, Santanilla JI, DeBlieux PM. Healthcare-associated pneumonia in the emergency department. Semin Respir Crit Care Med 2009;30:46-51.
2. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
3. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-84.
4. Tambyah PA, Habib AG, Ng TM, Goh H, Kumarasinghe G. Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually "healthcare associated". Infect Control Hosp Epidemiol 2003;24:436-8.
5. Hiramatsu K, Niederman MS. Health-care-associated pneumonia: a new therapeutic paradigm. Chest 2005;128:3784-7.
6. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128:3854-62.
7. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007;51:3568-73.
8. Carratalà J, Mykietiuk A, Fernández-Sabé N, Suárez C, Dorca J, Verdaguer R, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007;167:1393-9.
9. Kim IK. Demographic transition and population aging in Korea. Korea J Popul Dev 1996;25:27-40.
10. Hwang SS, Lee JH, Jung GW, Lim JH, Kwon HJ. [Spatial analysis of air pollution and lung cancer incidence and mortality in 7 metropolitan cities in Korea]. J Prev Med Public Health 2007;40:233-8.
11. Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Hashimoto N, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009;135:633-40.
12. Venditti M, Falcone M, Corrao S, Licata G, Serra P; Study Group of the Italian Society of Internal Medicine. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009;150:19-26.
13. Kollef MH, Morrow LE, Baughman RP, Craven DE, McGowan JE Jr, Micek ST, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit. Clin Infect Dis 2008; 46 Suppl 4:S296-334.
14. Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010;10:279-87.
15. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50.
16. Maruyama T, Niederman MS, Kobayashi T, Kobayashi H, Takagi T, D'Alessandro-Gabazza CN, et al. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir Med 2008;102:1287-95.
17. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Adrisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infec Control 2007;35(10 Suppl 2):S165-93.
18. Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001;18:362-8.
19. Song JH, Oh WS, Kang CI, Chung DR, Peck KR, Ko KS, et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents 2008;31:107-14.
20. Matsushima T, Miyashita N, File TM, Jr. Etiology and management of community-acquired pneumonia in Asia. Curr Opin Infect Dis 2002;15:157-62.
21. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 1996;22: 387-94.
22. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998;113:412-20.
23. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96.
24. El-Solh AA, Sikka P, Ramadan F, Davies J. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 2001; 163(3 Pt 1):645-51.